The GLP-1 analogue exenatide (Byetta) was developed from the venom of a Mexican lizard and Australian scientists are now aiming to go one better and source a superior incretin mimetic from the duck billed platypus. Adelaide researchers have already characterised a unique form of glucagon-like peptide-1 from the monotreme and are now investigating whether the ...
Platypus venom may contain a better version of GLP-1 receptor agonist
By Michael Woodhead
20 Jun 2018